A new multilingual glossary of amyloidosis-related medical terms is now available to help patients better understand their diagnosis and communicate with care teams across borders.
Developed with input from patient organizations in eight languages, the glossary covers key terms used in diagnosis, treatment, and clinical trial documentation.